Hormonal contraception among electronic cigarette users and cardiovascular risk: a systematic review

详细信息    查看全文

• 作者：Halley E.M. Riley^a ; ^{heriley@emory.edu" class="auth_mail" title="E-mail the corresponding author} ; Erin Berry-Bibee^a ; Lucinda J. England^b ; Denise J. Jamieson^a ; Polly A. Marchbanks^a ; Kathryn M. Curtis^a
• 关键词：Electronic cigarettes ; Hormonal contraceptives ; Nicotine ; Propylene glycol ; Glycerol ; Cardiovascular disease
• 刊名：Contraception
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：93
• 期：3
• 页码：190-208
• 全文大小：317 K

文摘

Women who use combined hormonal contraceptives and cigarettes have an increased risk for cardiovascular (CV) events. We reviewed the literature to determine whether women who use hormonal contraceptives (HC) and electronic cigarettes (e-cigarettes) also have an increased risk.

Study Design

Systematic review.

Methods

We searched for articles reporting myocardial infarction (MI), stroke, venous thromboembolism, peripheral arterial disease or changes to CV markers in women using e-cigarettes and HC. We also searched for indirect evidence, such as CV outcomes among e-cigarette users in the general population and among HC users exposed to nicotine, propylene glycol or glycerol.

Results

No articles reported on outcomes among e-cigarette users using HC. Among the general population, 13 articles reported on heart rate or blood pressure after e-cigarette use. These markers generally remained normal, even when significant changes were observed. In three studies, changes were less pronounced after e-cigarette use than cigarette use. One MI was reported among 1012 people exposed to e-cigarettes in these studies. One article on nicotine and HC exposure found both exposures to be significantly associated with acute changes to heart rate, though mean heart rate remained normal. No articles on propylene glycol or glycerol and HC exposure were identified.

Conclusion

We identified no evidence on CV outcomes among e-cigarette users using HC. Limited data reporting mostly acute outcomes suggested that CV events are rare among e-cigarette users in the general population and that e-cigarettes may affect heart rate and blood pressure less than conventional cigarettes. There is a need for research assessing joint HC and e-cigarette exposure on clinical CV outcomes.